W. Kolb

发表

Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury.

L. McManus, F. Grover, R. O'rourke, 1988, Circulation.

C1Q receptors on cultured human gingival fibroblasts: analysis of binding properties.

R. Page, S. Bordin, W. Kolb, 1983, Journal of immunology.

Antithrombin III binding to SC5b-9 attack complexes of human complement: dissociation of a modified antithrombin III derivative subsequent to complex formation.

W. Kolb, L. M. Kolb, 1983, Biochemistry.

C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay.

E. Podack, W. Kolb, L. M. Kolb, 1979, Journal of immunology.

Characterization of the binding of purified human C1q to heart mitochondrial membranes.

M. Olson, R. N. Pinckard, S. B. Storrs, 1981, The Journal of biological chemistry.

Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines.

J. White, G. Moore, G. Granger, 1970, Journal of immunology.

Nonimmunologic complement activation in normal human serum induced by radiographic contrast media.

J. Lang, E. Lasser, W. Kolb, 1978, Journal of immunology.

Steroids: theoretical and experimental basis for utilization in prevention of contrast media reactions.

J. Lang, E. Lasser, M. Sovák, 1977, Radiology.

Activation of serum complement by contrast media.

J. Lang, E. Lasser, W. Kolb, 1976, Investigative radiology.

Contrast Media Activation of Serum Complement System

J. Lang, E. Lasser, W. Kolb, 1974 .

Activation of the fifth component of human complement (C5) induced by monosodium urate crystals: C5 convertase assembly on the crystal surface.

I. Russell, W. Kolb, L. M. Kolb, 1982, Clinical immunology and immunopathology.

The presence of the fifth component of complement (C5) in rabbit uterine flushings in relation to reproductive state.

M. Jones, M. Harper, W. Kolb, 1988, Immunological investigations.

Neoantigens of the membrane attack complex of human complement.

H. Müller-Eberhard, J. Curd, H. J. Muller-Eberhard, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Complement localization in ischemic baboon myocardium.

L. McManus, F. Grover, R. O'rourke, 1983, Laboratory investigation; a journal of technical methods and pathology.

Plasma terminal complement complexes in acute poststreptococcal glomerulonephritis.

R. Wyatt, D. Matsell, J. Tamerius, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Molecular reorganization of lipid bilayers by complement: a possible mechanism for membranolysis.

H. Müller-Eberhard, E. Podack, W. Kolb, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Biochemical characterization of the sixth component (C6) of human complement.

W. Kolb, L. M. Kolb, J. Savary, 1982, Biochemistry.

Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes

Rena Li, G. Ahern, J. Rogers, 2006, Neurobiology of Aging.

Complement and coagulation: causative considerations in contrast catastrophies.

J. Lang, J. Slivka, E. Lasser, 1979, AJR. American journal of roentgenology.

WETSEL AND KOLB

R. Wetsel, W. Kolb, 2003 .

Genomics-guided discovery of a new and signi fi cantly better source of anticancer natural drug FK 228

R. Wetsel, W. Kolb, 2003 .

The SC5b-7 complex: formation, isolation, properties, and subunit composition.

H. Müller-Eberhard, E. Podack, W. Kolb, 1977, Journal of immunology.

Induction of acute pulmonary inflammation. A differential effect of C5 and the 200,000 molecular weight form of trypsin-activated C5 (C5').

J. Collins, S. Fowler, J. Seidenfeld, 1987, The American review of respiratory disease.

Human lymphotoxin: purification and some properties.

G. Granger, W. Kolb, E. C. Laserna, 1973, Proceedings of the National Academy of Sciences of the United States of America.

Letter: Contrast media activation of serum complement system.

J. Lang, E. Lasser, W. Kolb, 1974, Investigative radiology.

Complement-independent activation of the fifth component (C5) of human complement: limited trypsin digestion resulting in the expression of biological activity.

R. Wetsel, W. Kolb, 1982, Journal of immunology.

Lymphocyte in vitro Cytotoxicity: Specific Release of Lymphotoxin-like Materials from Tuberculin-sensitive Lymphoid Cells

G. Granger, T. Williams, S. Shacks, 1969, Nature.

Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin.

G. Granger, W. Kolb, 1970, Cellular immunology.

Complement activation in psoriasis

R. Wyatt, E. Rosenberg, W. Kolb, 1990, Clinical and experimental dermatology.

Human platelet-initiated formation and uptake of the C5-9 complex of human complement.

T. Zimmerman, W. Kolb, T. S. Zimmerman, 1976, The Journal of clinical investigation.

Physicochemical characterization of fluid phase (SC5b-9) and membrane derived (MC5b-9) attack complexes of human complement purified by immunoadsorbent affinity chromatography or selective detergent extraction.

C. Ware, R. Wetsel, W. Kolb, 1981, Molecular immunology.

MOLECULAR ANALYSIS OF THE MEMBRANE ATTACK MECHANISM OF COMPLEMENT

H. Müller-Eberhard, J. Haxby, C. Arroyave, 1972, The Journal of experimental medicine.

Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction.

G. Granger, G A Granger, W P Kolb, 1968, Journal of immunology.

Assembly of the functional membrane attack complex of human complement: formation of disulfide-linked C9 dimers.

C. Ware, W. Kolb, 1981, Proceedings of the National Academy of Sciences of the United States of America.

H. Müller-Eberhard, E. Podack, W. Kolb, 1979, Journal of immunology.

The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex

W. Kolb, H. Muller-Eberhard, H. J. MULLER-EBERHARD, 1975, The Journal of experimental medicine.

Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide

B. Bradt, N. Cooper, W. Kolb, 1998, The Journal of experimental medicine.

The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum.

H. Müller-Eberhard, E. Podack, W. Kolb, 1978, Journal of immunology.

SC5b-9: Regeneration of the Ability to Interact with Lipid by Selective Removal of the S-Protein

H. Müller-Eberhard, E. Podack, C. Halverson, 1978, The Journal of Immunology.

Synthesis of complement component C5 by human B and T lymphoblastoid cell lines

B. Myones, W. Reed, G. D. Ross, 2004, Immunogenetics.

THE MEMBRANE ATTACK MECHANISM OF COMPLEMENT

H. Müller-Eberhard, W. Kolb, 1973, The Journal of experimental medicine.

Purification of the sixth and seventh component of human complement without loss of hemolytic activity.

H. Müller-Eberhard, E. Podack, W. Kolb, 1976, Journal of immunology.

Complement‐dependent induction of DNA synthesis and proliferation of human diploid fibroblasts

R. Page, J. Clagett, W. Kolb, 1980, Journal of cellular physiology.

C1q binding and C1 activation by various isolated cellular membranes.

M. Olson, S. B. Storrs, W. Kolb, 1983, Journal of immunology.

Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin.

G. Granger, W. Kolb, 1968, Proceedings of the National Academy of Sciences of the United States of America.

14 – LYMPHOCYTE ACTIVATION AND LYMPHOTOXIN PRODUCTION

G. Granger, T. Williams, W. Kolb, 1971 .

Fluorometric detection of low temperature thermal transitions in the C1Q component of human complement.

Z. Wasylewski, P. Horowitz, W. Kolb, 1980, Biochemical and biophysical research communications.

Immunoadsorbent affinity purification of the fifth component (C5) of human complement and development of a highly sensitive hemolytic assay.

M. Jones, R. Wetsel, W. Kolb, 1980, Journal of immunological methods.

Biological effects of short-term, high-concentration exposure to methyl isocyanate. VI. In vitro and in vivo complement activation studies.

D. Dodd, J. Tamerius, W. Kolb, 1987, Environmental health perspectives.

Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments

R. Wetsel, W. Kolb, 1983, The Journal of experimental medicine.

Mode of action of human C9: adsorption of multiple C9 molecules to cell-bound C8.

H. Müller-Eberhard, W. Kolb, 1974, Journal of immunology.

REACTIONS OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES WITH C5b-9 COMPLEMENT COMPLEX-SPECIFIC ANTIBODIES

H. J. Muller-Eberhard, J. Sundsmo, W. Kolb, 1977 .

Leukocyte complement: assembly of the membrane attack complex of complement by human peripheral blood leukocytes in the presence and absence of serum.

H. Müller-Eberhard, J. Curd, J. Sundsmo, 1978, Journal of Immunology.

Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.

J. Sodetz, W. Kolb, J. L. Stewart, 1987, Journal of immunology.

The complement system in ischemic heart disease.

I. Toda, K. Takeuchi, H. Iida, 1990, Circulation.

Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples.

J. Tamerius, W. Kolb, P. R. Morrow, 1989, Complement and inflammation.

The C5b-6 complex: reaction with C7, C8, C9.

H. Müller-Eberhard, E. Podack, G. Biesecker, 1978, Journal of immunology.

THE MEMBRANE ATTACK MECHANISM OF COMPLEMENT

H. Müller-Eberhard, J. Haxby, C. Arroyave, 1973, The Journal of experimental medicine.

Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin.

G. Granger, W. Kolb, 1970, Cellular immunology.